首页> 外文会议>International Conference on Environmental Stressors in Biology and Medicine >Development of a Metabolomics Platform for in vivo Assessment of Impacts of Xenobiotics on the CNS
【24h】

Development of a Metabolomics Platform for in vivo Assessment of Impacts of Xenobiotics on the CNS

机译:制定一种代谢组合平台的体内评估Xenobiotics对CNS的影响

获取原文

摘要

Since metabolites are the downstream products of gene expression, such a metabolomics platform would provide an instantaneous snapshot of biochemical abundances, and form a more popular tool for the identification of useful biomarkers of disease and exposure to xenobiotics; and for the elucidation of biological pathways / molecular mechanisms of pharmacological effect and toxicity. In our studies, we have developed a metabolomics platform on neurotransmitters in Oryzias melastigma to study complex diseases and effects of xenobiotics on the neuropathways of the central nervous system (CNS) in vertebrates.
机译:由于代谢物是基因表达的下游产物,因此这种代谢组合性平台将提供生化丰富的瞬时快照,并形成更受疾病的有用生物标志物和暴露于异种症的更普遍的工具;并阐明生物途径/药理学效应和毒性的分子机制。在我们的研究中,我们在Oryzias MelaStigma中开发了一种代谢组织平台,用于研究脊椎动物中枢神经系统(CNS)神经病变的复杂疾病和仇外作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号